Quick Answer
CAPRICOR THERAPEUTICS, INC. reported Net Income Loss of -$105.04 million for the year ending 2025.
- CAPRICOR THERAPEUTICS, INC. showed a decrease of -159.6% in Net Income Loss from 2024 to 2025.
- This data is from CAPRICOR THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
- XBRL data for this metric is available from 2006 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 20 years of available data (2006 to 2025), CAPRICOR THERAPEUTICS, INC.'s Net Income Loss has declined by 8,867.2%.
- Historical annual values: Fiscal year 2025: -$105.04 million | Fiscal year 2024: -$40.47 million | Fiscal year 2023: -$22.29 million | Fiscal year 2022: -$29.02 million | Fiscal year 2021: -$20.02 million | Fiscal year 2020: -$13.66 million | Fiscal year 2019: -$7.64 million | Fiscal year 2018: -$15.19 million | Fiscal year 2017: $2.43 million | Fiscal year 2016: -$18.81 million | Fiscal year 2015: -$12.86 million | Fiscal year 2014: -$6.22 million | Fiscal year 2013: -$8.89 million | Fiscal year 2012: -$2.07 million | Fiscal year 2011: -$1.15 million | Fiscal year 2010: -$1.06 million | Fiscal year 2009: -$149.0 thousand | Fiscal year 2008: -$630.9 thousand | Fiscal year 2007: -$979.1 thousand | Fiscal year 2006: -$1.17 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: